指标 | 对照组(n = 60) | 观察组(n = 60) | t/Z | P | |
LVEF | 前 | 36.97 ± 2.24 | 36.67 ± 2.37 | −0.402 | 0.688 |
后 | 39.53 ± 1.81 | 43.50 ± 3.07 | −6.091 | 0.000 | |
LVDD | 前 | 53.53 ± 6.30 | 55.93 ± 6.21 | 1.504 | 0.133 |
后 | 52.63 ± 4.97 | 49.57 ± 6.07 | 2.143 | 0.036 | |
LVMI | 前 | 130.93 ± 5.51 | 133.37 ± 5.75 | −1.327 | 0.184 |
后 | 123.93 ± 5.27 | 120.50 ± 2.83 | 3.144 | 0.003 | |
HR | 前 | 87.47 ± 15.65 | 81.73 ± 11.24 | 1.63 | 0.109 |
后 | 75.60 ± 10.34 | 70.00 ± 8.51 | 2.29 | 0.026 | |
NT-proBNP | 前 | 7097.99 ± 10037.86 | 7177.03 ± 9070.36 | −0.222 | 0.824 |
后 | 3483.17 ± 4012.31 | 2640.40 ± 3707.92 | −2.07 | 0.038 | |
TNT-HS | 前 | 36.58 ± 21.61 | 68.95 ± 107.68 | −0.747 | 0.455 |
后 | 26.80 ± 12.87 | 22.07 ± 13.25 | −2.632 | 0.008 | |
eGFR | 前 | 70.05 ± 19.36 | 65.87 ± 18.27 | 0.859 | 0.394 |
后 | 72.29 ± 13.73 | 79.68 ± 14.27 | 2.045 | 0.045 |